Two dietary supplements made by the same company don’t have enough in common to warrant pre-trial consolidation, the U.S. Judicial Panel on Multidistrict Litigation has ruled.
Defendant USPlabs LLC had moved to consolidate litigation over two of its dietary supplements, OxyElite Pro and Jack 3d, in the U.S. District Court in the Eastern District of Pennsylvania or the Western District of Texas. Some codefendants and plaintiffs supported centralization in federal multidistrict litigation, while others did not.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
